Company / Operating Cash Flow per Share
IDEAYA Biosciences, Inc. Operating Cash Flow per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.82
FY2025
5-year range
-$3.81 / $1.44
FY2021-FY2025
Trend
+78.4%
vs FY2024
Sector context
#109 of 212
Health Care
What the data says
At $-0.82, IDEAYA Biosciences, Inc.'s operating cash flow per share ranks #109 of 212 in the Health Care sector. Operating Cash Flow per Share returned to growth in FY2025 after 2 years of decline, reaching $-0.82.
Based on SEC 10-K filings.
-0.82 in FY2025.
Improved from $-2.39 to $-0.82 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#109 of 212 in Health CareTop 51% of 212This company -$0.82 Sector average $5.28
▼
-115.6% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 78.4% year-over-year.
- Ranks #109 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2022.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.55 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.82 | +78.4% |
| FY2024 | -$3.81 | -59.2% |
| FY2023 | -$2.39 | -266.1% |
| FY2022 | $1.44 | +208.1% |
| FY2021 | -$1.33 | +2.0% |
| FY2020 | -$1.36 | +56.8% |
| FY2019 | -$3.15 | +89.1% |
| FY2018 | -$28.88 | -64.3% |
| FY2017 | -$17.58 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026